慢性胰腺炎患者循证管理算法的实施(COMBO试验):阶梯楔形整群随机对照试验的研究方案
COMBO试验为全国性阶梯楔形整群随机对照试验,26个中心按6个健康区域逐步从现行实践转换为遵循循证整合管理算法的诊疗。研究评估患者教育及诊疗标准化对慢性胰腺炎患者生活质量和疼痛程度的影响,共同主要终点为PANQOLI评分和Izbicki问卷疼痛水平,标准随访35个月。
要点
- COMBO试验采用阶梯楔形整群随机设计,26个中心分6个健康区域逐步交叉至循证管理算法。
- 共同主要终点为生活质量(PANQOLI评分)和疼痛程度(Izbicki问卷)。
- 个体患者数据同时贡献于现行实践期和干预期两个研究阶段。
核心结论
- 这是首个采用阶梯楔形整群随机对照设计、评估循证整合治疗路径较现行实践能否改善慢性胰腺炎患者生活质量和疼痛严重程度的试验。
研究设计与样本
- COMBO试验为全国性阶梯楔形整群随机对照试验,26个中心按6个健康区域分步从现行实践交叉至循证整合管理算法。
- 现行实践阶段招募研究对象并通过问卷进行纵向随访,个体患者数据同时贡献于两个研究阶段。
- 标准随访时间为自试验开始起35个月。
主要发现
- 共同主要终点为生活质量(PANQOLI评分评估)和疼痛程度(Izbicki问卷评估)。
- 次要结局包括流程指标、临床结局(如胰腺功能、营养状态、骨骼健康、干预措施、药物使用)、医疗资源利用、(间)接费用及社会参与水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic pancreatitis (CP) is an inflammatory disease that may be complicated by abdominal pain, pancreatic dysfunction, nutritional deficiencies, and diminished bone density. Importantly, it is also associated with a substantially impaired quality of life and reduced life expectancy. This may partly be explained by suboptimal treatment, in particular the long-term management of this chronic condition, despite several national and international guidelines. Standardization of care through a structured implementation of guideline recommendations may improve the level of care and lower the complication rate of these patients. Therefore, the aim of the present study is to evaluate to what extent patient education and standardization of care, through the implementation of an evidence-based integrated management algorithm, improve quality of life and reduce pain severity in patients with CP. METHODS: The COMBO trial is a nationwide stepped-wedge cluster-randomized controlled trial. In a stepwise manner, 26 centers, clustered in 6 health regions, cross-over from current practice to care according to an evidence-based integrated management algorithm. During the current practice phase, study participants are recruited and followed longitudinally through questionnaires. Individual patients contribute data to both study periods. Co-primary study endpoints consist of quality of life (assessed by the PANQOLI score) and level of pain (assessed by the Izbicki questionnaire). Secondary outcomes include process measure outcomes, clinical outcomes (e.g., pancreatic function, nutritional status, bone health, interventions, medication use), utilization of healthcare resources, (in) direct costs, and the level of social participation. Standard follow-up is 35 months from the start of the trial. DISCUSSION: This is the first stepped-wedge cluster-randomized controlled trial to investigate whether an evidence-based integrated therapeutic approach improves quality of life and pain severity in patients with CP as compared with current practice. TRIAL REGISTRATION: ISRCTN, ISRCTN13042622. Registered on 5 September 2020.
引用
- de Rijk FEM, van Veldhuisen CL, Besselink MG, et al. Implementation of an evidence-based management algorithm for patients with chronic pancreatitis (COMBO trial): study protocol for a stepped-wedge cluster-randomized controlled trial. Trials. 2023. PMID: 36611202. doi:10.1186/s13063-022-07044-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。